This company has been acquired
Apollo Endosurgery Future Growth
Future criteria checks 2/6
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment earnings growth | 12.6% |
| Revenue growth rate | 32.1% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 05 Apr 2023 |
Recent future growth updates
Recent updates
Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?
Apr 03
Is Apollo Endosurgery (NASDAQ:APEN) Weighed On By Its Debt Load?
Nov 30Is Apollo Endosurgery (NASDAQ:APEN) Using Too Much Debt?
Aug 05Apollo Endosurgery: Collect Shares At A Discount Following Q2 Earnings
Aug 04Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?
Mar 02Is Apollo Endosurgery, Inc. (NASDAQ:APEN) Trading At A 20% Discount?
Aug 04Apollo Endosurgery: New Management Bounce Makes Weight Loss Specialist A Buy
Jun 28Is Apollo Endosurgery (NASDAQ:APEN) A Risky Investment?
May 05A Look At The Intrinsic Value Of Apollo Endosurgery, Inc. (NASDAQ:APEN)
Mar 24What Percentage Of Apollo Endosurgery, Inc. (NASDAQ:APEN) Shares Do Insiders Own?
Mar 03Trade Alert: Neil Gagnon At Apollo Endosurgery, Inc. (NASDAQ:APEN), Has Just Spent US$146k Buying 2.8% More Shares
Feb 10We Think Apollo Endosurgery (NASDAQ:APEN) Has A Fair Chunk Of Debt
Jan 31If You Had Bought Apollo Endosurgery's (NASDAQ:APEN) Shares Three Years Ago You Would Be Down 36%
Dec 27Is It Too Late To Consider Buying Apollo Endosurgery, Inc. (NASDAQ:APEN)?
Dec 01Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 181 | N/A | -31 | N/A | 1 |
| 12/31/2024 | 117 | N/A | -28 | N/A | 1 |
| 12/31/2023 | 89 | -34 | -30 | N/A | 2 |
| 12/31/2022 | 77 | -40 | -34 | -31 | N/A |
| 9/30/2022 | 72 | -41 | -28 | -25 | N/A |
| 6/30/2022 | 68 | -36 | -25 | -23 | N/A |
| 3/31/2022 | 66 | -28 | -21 | -19 | N/A |
| 12/31/2021 | 63 | -25 | -16 | -14 | N/A |
| 9/30/2021 | 60 | -18 | -14 | -13 | N/A |
| 6/30/2021 | 56 | -14 | -15 | -14 | N/A |
| 3/31/2021 | 45 | -17 | -19 | -19 | N/A |
| 12/31/2020 | 42 | -23 | -21 | -21 | N/A |
| 9/30/2020 | 41 | -26 | -26 | -25 | N/A |
| 6/30/2020 | 40 | -32 | -27 | -26 | N/A |
| 3/31/2020 | 48 | -35 | -27 | -26 | N/A |
| 12/31/2019 | 51 | -27 | -27 | -26 | N/A |
| 9/30/2019 | 54 | -39 | -24 | -23 | N/A |
| 6/30/2019 | 57 | -40 | -21 | -20 | N/A |
| 3/31/2019 | 58 | -40 | -24 | -22 | N/A |
| 12/31/2018 | 61 | -46 | -26 | -23 | N/A |
| 9/30/2018 | 62 | -35 | -26 | -23 | N/A |
| 6/30/2018 | 64 | -30 | -27 | -24 | N/A |
| 3/31/2018 | 66 | -27 | -20 | -17 | N/A |
| 12/31/2017 | 64 | -27 | -15 | -13 | N/A |
| 9/30/2017 | 64 | -33 | -18 | -16 | N/A |
| 6/30/2017 | 63 | -36 | -16 | -14 | N/A |
| 3/31/2017 | 63 | -41 | -14 | -12 | N/A |
| 12/31/2016 | 65 | -41 | -15 | -13 | N/A |
| 9/30/2016 | 66 | -36 | N/A | -8 | N/A |
| 6/30/2016 | 66 | -38 | N/A | -7 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if APEN's forecast earnings growth is above the savings rate (2.1%).
Earnings vs Market: Insufficient data to determine if APEN's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if APEN's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: APEN's revenue (32.1% per year) is forecast to grow faster than the US market (6.9% per year).
High Growth Revenue: APEN's revenue (32.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if APEN's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/04/06 14:06 |
| End of Day Share Price | 2023/04/03 00:00 |
| Earnings | 2022/12/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Apollo Endosurgery, Inc. is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matthew Hewitt | Craig-Hallum Capital Group LLC |
| Frank Takkinen | Lake Street Capital Markets, LLC |
| Suraj Kalia | Northland Capital Markets |